perspectives
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
April 24, 2023
Cultivating A Dynamic Culture Centered Around Purpose-Driven Values
By Kate Mitchell, Vice President, Head of Human Resources
Read more
Sep 15, 2022 |
Lessons Learned on Preparing to Weather the Inevitable Challenges in Biotech
by Joshua Brumm,
President & CEO of Dyne
Oct 7, 2021 |
From the Trenches: A LifeSci VC blog
by Josh Brumm
Read moreSep 15, 2021 | Blog
Starting a New Tradition of Support
by Molly White, Dyne’s vice president, global head of patient advocacy and engagement
Read moreJul 8, 2021 |
Playing To Win: Building A Position Of Strength In Biotech
by Josh Brumm
Read moreApril 28, 2021 | BLOG
Toward a brighter future: targeting the genetic basis of rare muscle diseases
By Romesh Subramanian, Ph.D.
Read moreApril 8, 2021 | BLOG
Scaling culture with growth: how to maintain your startup’s “special sauce”
By Joshua Brumm
Read moreJan 8, 2021 | Life Science Leader panel
Preparing to pitch in a virtual world
Featuring Joshua Brumm
WatchDec 16, 2020 | BLOG
Beyond the balance sheet: thinking broadly about dilution in building a transformative biotech
By Joshua Brumm
Read moreDec 14, 2020 | BLOG
Voice of the patient – the biopharma perspective
By Molly White
Read moreAdditional content
Hear more from Dyne Therapeutics
;
We’ll be presenting at the 42nd Annual @jpmorgan Healthcare Conference on Jan. 9 at 2:15 p.m. PT where we’ll provide a company overview & recap our recently announced positive clinical data from our ACHIEVE & DELIVER trials: https://bit.ly/48I10zz #JPM24 #JPM2024 $DYN #DM1 #DMD
